Thrombotic Microangiopathy Caused by Gemcitabine in a Patient with Duodenal Cancer
<p>Gemcitabine (2',2'-difl uorodeoxycytidine) is a potent pyrimidine antimetabolite and was introduced in 1987. It is commonly used for various tumors including non-small cell lung cancer, pancreatic cancer, breast cancer, ovarian can cer and renal cell carcinoma at advanced stages....
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
Archives of Clinical Nephrology - Peertechz Publications,
2017-03-27.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|